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Abstract 28 
The diagnosis of equine asthma is currently based on the presence of clinical signs indicative of a 29 
lower airway disease combined with abnormal bronchoalveolar lavage fluid (BALF) cytology 30 
results. However, the type and degree of lower airway inflammation is not correlated with the 31 
severity of the clinical signs, and it does not prognosticate on the progression of the disease. We 32 
summarize here the results of recent work published in non-veterinary journals or presented at 33 
veterinary congresses reporting on the structural alterations (remodeling) occurring in the equine 34 
asthmatic airways and their relationship with lung function and inflammation. Using archived 35 
tissues, endobronchial and thoracoscopic peripheral lung biopsies, remodeling was found to occur 36 
in both central and peripheral airways. The observed changes included increased in the smooth 37 
muscle mass, fibrosis, and deposition of elastic fibers, which were correlated with the lung function. 38 
Endobronchial biopsies and endobronchial ultrasound are new methods that have been validated for 39 
the non-invasive assessment of remodeling and inflammation in the central airways of clinical 40 
equine cases, which reflect peripheral airway lesions. The future implementation of these methods 41 
could change the clinical approach to equine asthma in favor of an early recognition of the 42 
condition for its prevention, and hopefully, for the development of targeted therapies to prevent, or 43 
even reverse, established tissue remodeling and inflammation. 44 
 45 
  46 
It has long been known that the domestication of horses led to the development of chronic non-47 
infectious small airway diseases. The terminology used to describe these conditions has evolved in 48 
parallel with findings related to their clinical, anatomical, histologic, or functional features. Heaves, 49 
equine emphysema, chronic bronchiolitis, equine chronic obstructive pulmonary disease (COPD), 50 
summer pasture associated obstructive pulmonary disease (SPAOPD), lower airway diseases, 51 
recurrent airway obstruction (RAO), and inflammatory airway disease (IAD) have been used either 52 
interchangeably or to describe specific manifestations or characteristic of the disease. As new 53 
features (functional, anatomical, and pathobiological) of these conditions are emerging, the term 54 
«equine asthma» has been proposed [1], given its many similarities with human asthma [2].   55 
Driven by the incurable nature of the condition in some horses, and the progression of clinical signs 56 
often leading to premature retirement or even euthanasia in its severe form, our research group has 57 
focused its attention on the alterations (remodeling) affecting the lower airways and their response 58 
to current therapies. We will summarize here recent findings that may change the paradigm 59 
dictating the clinical approach to equine asthma in favor of an early recognition of the condition for 60 
its prevention, and hopefully, the development of targeted therapies to prevent, or even reverse, 61 
established tissue remodeling. Although BAL cytology remains the cornerstone of the diagnosis of 62 
equine asthma, novel diagnostic methods have been developed to assess the remodeling affecting 63 
the equine airways and to eventually identify horses predisposed to progress to the severe 64 
phenotype. 65 
 66 
Equine asthma: definitions and diagnostic challenges 67 
Based on the severity of clinical signs, equine asthma may be divided into three main phenotypes, 68 
namely mild, moderate, and severe. Mild equine asthma comprises horses with lower airway 69 
inflammation identified by bronchoalveolar lavage fluid (BALF) cytology or abnormal lung 70 
function, presenting clinical signs of airway diseases that may be limited to a decreased 71 
performance. The clinical signs of horses with moderate equine asthma are more obvious and 72 
usually include coughs and possibly tachypnea at rest. These conditions were previously known as 73 
IAD. Severe equine asthma (heaves, RAO, SPAOPD, equine emphysema and COPD) comprises all 74 
cases characterized by recurrent episodes of increased respiratory effort at rest (labored breathing), 75 
which is at least partially reversible with therapy [3].  76 
The clinical diagnosis of equine asthma should ideally be based on the documentation of lower 77 
airway obstruction; however, the lack of sensitive and portable lung function tests currently 78 
prevents this approach in clinical practice. For these reasons, the diagnosis currently relies on 79 
history, clinical signs, and in the presence of lower airway inflammation as detected by BALF 80 
cytology. The rationale behind this approach comes from the groundbreaking work of Dr. Viel who 81 
reported that the neutrophilia in BALF cytology correlated with the severity of the pulmonary 82 
lesions [4]. Another descriptive study also speculated on a possible correlation between the small 83 
airway lesions and the clinical severity [5]. However, the clinical significance of BALF 84 
inflammation deserves further investigations as the cut-off normal values for the different cell types 85 
in BALF have recently been questioned, and little is known on the relationship between the degree 86 
and type of BALF inflammation, the severity of disease, and the response to therapy. 87 
 88 
What is the clinical significance of bronchoalveolar lavage inflammation in equine asthma? 89 
There is no data in the literature clearly linking the degree and type of bronchoalveolar 90 
inflammation to specific pulmonary lesions in asthmatic horses. That is, how should a clinician 91 
interpret an increase in neutrophil vs. mast cell or eosinophil differential cell count in equine 92 
asthma? What is the clinical implication of a mild vs. a moderate increase in either of these cell 93 
populations? Normal cut-off values for inflammatory cell percentages in BALF have been 94 
established, but they provide practitioners no clues concerning the severity of the pulmonary lesions 95 
associated with the disease or to the prognosis in terms of progression and reversibility of the 96 
disease. Lastly, several studies have shown that BALF neutrophilia does not normalize after 97 
effective treatment with inhaled or systemic corticosteroids when horses are kept in the offending 98 
environment [6; 7]. These findings add further complexity to our ability to interpret the clinical 99 
meaning of BALF inflammation in everyday practice, when horses are under different management 100 
conditions, and receiving different asthma medications. 101 
In this perspective, our group has recently studied in well-characterized mild and severely asthmatic 102 
horses the relationship between the severity of specific pulmonary lesions and BALF neutrophilia 103 
[8]. The results show that in mild equine asthma, luminal neutrophilia (>5% in BALF) is associated 104 
with the presence of acute (neutrophilic) bronchiolitis. However, no association was found with the 105 
structural alterations present in the small airways and in the pulmonary parenchyma. Conversely, in 106 
severe equine asthma, two different cytological phenotypes were observed: a classical neutrophilic 107 
phenotype (>20%) and a paucigranulocytic phenotype, characterized by a moderate (5-20%) or by a 108 
lack of increase in neutrophils at BALF cytology. Unexpectedly, in neutrophilic severe equine 109 
asthma, the peripheral airway lesions were milder than those observed in paucigranulocytic cases. 110 
Paucigranulocytemia was also associated with peripheral mucostasis, which was not detected in 111 
horses with the neutrophilic phenotype. The presence of mucostasis could explain the reduced 112 
BALF neutrophilia in this group, as mucus plugs could prevent the most peripheral bronchioles and 113 
alveoli to be reached and sampled during the BAL procedure. However, if this was the case, a 114 
decrease in macrophages rather than neutrophil differential cell count would have been expected 115 
due to the typically more distal location of these cells into the bronchial tree. Overall, these findings 116 
suggest a complex role for airway neutrophils in equine asthma pathophysiology, and the possibility 117 
that pulmonary neutrophils may sustain phenotypic switching as recently hypothesized in equine 118 
and human asthma [9; 10]. 119 
 120 
What’s beyond bronchoalveolar lavage cytology? 121 
Due to the absence of a significant association between lower airway inflammation detected with 122 
BALF cytology and the degree pulmonary dysfunction in equine asthma, the study of structural 123 
airway alterations (remodeling) affecting both the small and the large airways has recently gained 124 
interest in equine respiratory medicine and research.  125 
Early studies have described milder histological lesions in the central airways of asthmatic horses 126 
when compared to those observed in the peripheral airways [4; 11]. This was recently confirmed by 127 
our group using histomorphometric methods. On average, severe asthmatic horses have 300% more 128 
(i.e. 3 fold increase) airway smooth muscle in their peripheral airways when compared to those of 129 
age-matched healthy controls, while only a 50% increase is observed in central airways [12; 13]. 130 
This is important, as recent findings from a cohort of severely asthmatic horses (n=12) suggested 131 
that the clinical severity of the disease is correlated with the amount of peripheral smooth muscle 132 
[14]. The peripheral airway myocytes of severely asthmatic horses are also biochemically and 133 
functionally different from those isolated more cranially in the bronchial tree and trachea. Indeed, a 134 
specific myosine isoform ((+)insert), which is known to promote a faster contraction of the smooth 135 
muscle, is overexpressed in peripheral airways of asthmatic horses [15; 16].The changes are not 136 
limited to the smooth muscle layer, as there is also a deposition of collagen in the peripheral airway 137 
wall in asthmatic horses that is positively correlated with pulmonary resistance [17]. Also, the 138 
positive association between elastic fiber content and pulmonary elastance observed in controls is 139 
lost in asthmatic animals. Collectively, these findings indicate that there is a strong structure and 140 
function relationship in equine asthma, and that the remodeling of the airways represents a novel 141 
therapeutic target. 142 
Although the changes in the peripheral airways are more severe, the assessment of large airway 143 
smooth muscle remodeling by means of endobronchial ultrasound (EBUS) predicts the histological 144 
alterations occurring more distally within the bronchial tree [14]. EBUS is an imaging technique 145 
producing transversal scans of the bronchial wall using a miniature radial ultrasound probe inserted 146 
through the working channel of a videoendoscope. Also, when the histological alterations of the 147 
central airways are assessed using a newly developed score, a correlation with the severity of 148 
airway obstruction measured with the impulse oscillometry technique is observed [18]. This score 149 
evaluates the inflammation and remodeling affecting all the structures comprised within the 150 
bronchial wall. These two techniques (endobronchial biopsy and EBUS) have their own advantages 151 
and limitations [12; 18; 19]. Endobronchial biopsies are easy to obtain, and when processed for 152 
standard histology, they allow the assessment of airway epithelium, lamina propria, and smooth 153 
muscle. However, they do not permit a precise quantification of the deepest bronchial structures 154 
(smooth muscle, cartilage, and peribronchial tissues) [19]. Moreover, they are limited to the 155 
bronchial bifurcations (carinas) of the most proximal airways (up to 15 bronchial generations) and 156 
cannot be repeated over time at the same site, which limits their usefulness to monitor disease 157 
progression or treatment response. On the other hand, EBUS, a non-invasive imaging method 158 
performed during bronchoscopy that also evaluates the central airways, allows the cross-sectional 159 
study of the bronchial wall at all levels of the bronchial tree, and it can be repeated over time on the 160 
same airways. However, it differentiates the several bronchial structures less precisely than 161 
histology, it does not provide histological-grade detail, and it currently requires expensive 162 
equipment and technical expertise [12].  163 
Using these techniques, we have also studied how peripheral and central remodeling and 164 
inflammation respond to treatment in severely asthmatic horses. While inhaled corticosteroid 165 
monotherapy cannot reverse BALF neutrophilia unless concomitant antigen avoidance strategies are 166 
adopted, it is able to partially reverse peripheral smooth muscle remodeling after only 3 months of 167 
treatment [14]. Interestingly, a decrease in the fast contracting (+)isoform of myosine was observed 168 
after 3 months of inhaled corticosteroid monotherapy [15]. Also, a correlation was found between 169 
the maximal velocity of shortening of peripheral airway smooth muscle of asthmatic horses and the 170 
time elapsed since the end of their corticosteroid treatment [16]. The effects of corticotherapy on the 171 
peripheral airways are not potentiated by the administration of β2-agonist bronchodilators, at least in 172 
the first 3 months of treatment, while it better controls the airway neutrophilia and accelerates the 173 
reversal of collagen deposition in central airways [14]. Treatment duration must be prolonged up to 174 
12 months in order to significantly reduce peripheral collagen deposition, however [6]. Based on 175 
these results, the reversal of BALF neutrophilia observed in the horses treated with a combination 176 
of inhaled corticosteroids and β2-agonist bronchodilators was not associated with any specific 177 
parameter of central or peripheral remodeling and inflammation, again indicating the limited 178 
usefulness of BALF cytology when assessing response to therapy. 179 
 180 
Future directions 181 
Recent evidence suggests that although equine asthma is a disorder mainly affecting to the 182 
peripheral airways, alterations are present at all levels of the bronchial tree. Studying remodeling 183 
and inflammation occurring in the central and peripheral airways of horses with asthma of different 184 
severity could reveal important diagnostic or prognostic information. Indeed, there are currently no 185 
means to predict horses with mild asthma that would progress towards the severe form of the 186 
disease. Identifying early remodeling or inflammatory markers may fulfill this goal. In the field of 187 
equine respiratory research, an effort should be made to develop minimally invasive techniques for 188 
the study of both central and peripheral airway structures and function. Our results suggest that 189 
central airway remodeling could reflect structural changes occurring in the peripheral airways, at 190 
least for the smooth muscle compartment [14], but more studies are needed to confirm this theory 191 
and to investigate whether this is true for the remaining structures that make up the bronchial wall.  192 
Finally, the existence of an open equine respiratory tissue bank (www.brte.ca) represents an 193 
invaluable tool to further foster research collaboration in this field. Through this virtual platform, it 194 
is possible to gather information and have access to tissues harvested from well characterized 195 
asthmatic or healthy horses originating from different specialized centers all around the world. The 196 
routine collection of endobronchial biopsies in clinical practice after a BAL is performed would 197 
also accelerate the discovery of prognostic factors for the progression of the disease using real-life 198 
cases. 199 
 200 
  201 
References 202 
[1] Lavoie, J.P. (2015) Is the time primed for equine asthma? Equine Vet Educ 27, 225-226. 203 
 204 
[2] Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 205 
2016. Available from: www.ginasthma.org. 206 
 207 
[3] Couetil, L.L., Cardwell, J.M., Gerber, V., Lavoie, J.P., Leguillette, R. and Richard, E.A. 208 
(2016) Inflammatory Airway Disease of Horses-Revised Consensus Statement. J Vet Intern 209 
Med 30, 503-515. 210 
 211 
[4] Viel, L. (1983) Structural-functional correlationsof the lung in horses with small airway 212 
disease. PhD thesis, University of Guelph. 213 
 214 
[5] Kaup, F.J., Drommer, W., Damsch, S. and Deegen, E. (1990) Ultrastructural findings in 215 
horses with chronic obstructive pulmonary disease (COPD). II: Pathomorphological changes 216 
of the terminal airways and the alveolar region. Equine Vet J 22, 349-355. 217 
 218 
[6] Leclere, M., Lavoie-Lamoureux, A., Joubert, P., Relave, F., Lanctot Setlakwe, E., 219 
Beauchamp, G., Couture, C., Martin, J.G. and Lavoie, J.P. (2012) Corticosteroids and 220 
Antigen Avoidance Decrease Airway Smooth Muscle Mass in an Equine Asthma Model. 221 
Am J Respir Cell Mol Biol, 589-596. 222 
 223 
[7] Couetil, L.L., Art, T., de Moffarts, B., Becker, M., Melotte, D., Jaspar, F., Bureau, F. and 224 
Lekeux, P. (2006) Effect of beclomethasone dipropionate and dexamethasone isonicotinate 225 
on lung function, bronchoalveolar lavage fluid cytology, and transcription factor expression 226 
in airways of horses with recurrent airway obstruction. J Vet Intern Med 20, 399-406. 227 
 228 
[8] Bullone, M., Hélie, P., Lavoie, J.P. and Joubert, P. (2016) Role of airway luminal 229 
neutrophilia in equine asthma. In: 34th Veterinary Comparative Respiratory Society (VCRS) 230 
Symposium, East Lansing, USA. 231 
 232 
[9] Bruijnzeel, P.L., Uddin, M. and Koenderman, L. (2015) Targeting neutrophilic 233 
inflammation in severe neutrophilic asthma: can we target the disease-relevant neutrophil 234 
phenotype? J Leukoc Biol 98, 549-556. 235 
 236 
[10] Lavoie-Lamoureux, A., Moran, K., Beauchamp, G., Mauel, S., Steinbach, F., Lefebvre-237 
Lavoie, J., Martin, J.G. and Lavoie, J.P. (2010) IL-4 activates equine neutrophils and 238 
induces a mixed inflammatory cytokine expression profile with enhanced neutrophil 239 
chemotactic mediator release ex vivo. Am J Physiol Lung Cell Mol Physiol 299, L472-482. 240 
 241 
[11] Kaup, F.J., Drommer, W. and Deegen, E. (1990) Ultrastructural findings in horses with 242 
chronic obstructive pulmonary disease (COPD). I: Alterations of the larger conducting 243 
airways. Equine Vet J 22, 343-348. 244 
 245 
[12] Bullone, M., Beauchamp, G., Godbout, M., Martin, J.G. and Lavoie, J.P. (2015) 246 
Endobronchial Ultrasound Reliably Quantifies Airway Smooth Muscle Remodeling in an 247 
Equine Asthma Model. PLoS One 10, e0136284. 248 
 249 
[13] Herszberg, B., Ramos-Barbon, D., Tamaoka, M., Martin, J.G. and Lavoie, J.P. (2006) 250 
Heaves, an asthma-like equine disease, involves airway smooth muscle remodeling. Journal 251 
of Allergy and Clinical Immunology 118, 382-388. 252 
 253 
[14] Bullone, M. (2016) Reversibility of airway remodeling in equine asthma: contribution of 254 
anti-inflammatory and bronchodilator therapies. , Université de Montréal, Montréal. 255 
 256 
[15] Boivin, R., Vargas, A., Lefebvre-Lavoie, J., Lauzon, A.M. and Lavoie, J.P. (2014) Inhaled 257 
corticosteroids modulate the (+)insert smooth muscle myosin heavy chain in the equine 258 
asthmatic airways. Thorax 69, 1113-1119. 259 
 260 
[16] Matusovsky, O.S., Kachmar, L., Ijpma, G., Bates, G., Zitouni, N., Benedetti, A., Lavoie, J.P. 261 
and Lauzon, A.M. (2015) Peripheral Airway Smooth Muscle but not the Trachealis is 262 
Hypercontractile in an Equine Model of Asthma. Am J Respir Cell Mol Biol. 263 
 264 
[17] Setlakwe, E.L., Lemos, K.R., Lavoie-Lamoureux, A., Duguay, J.D. and Lavoie, J.P. (2014) 265 
Airway collagen and elastic fiber content correlates with lung function in equine heaves. Am 266 
J Physiol Lung Cell Mol Physiol 307, L252-260. 267 
 268 
[18] Bullone, M., Helie, P., Joubert, P. and Lavoie, J.P. (2016) Development of a 269 
Semiquantitative Histological Score for the Diagnosis of Heaves Using Endobronchial 270 
Biopsy Specimens in Horses. J Vet Intern Med 30, 1739-1746. 271 
 272 
[19] Bullone, M., Chevigny, M., Allano, M., Martin, J.G. and Lavoie, J.P. (2014) Technical and 273 
physiological determinants of airway smooth muscle mass in endobronchial biopsy samples 274 
of asthmatic horses. J Appl Physiol (1985) 117, 806-815. 275 
 276 
 277 
 278 
